ポリクローナル抗体の世界市場：製品別、用途別、投与経路別、供給源別、エンドユーザー別、予測（2023年～2032年）

世界のポリクローナル抗体の市場規模は、診断、治療、実験研究における応用範囲の拡大により、2023年～2032年にCAGR5.9％で成長すると予測されています。

ライフサイエンスとバイオテクノロジーの研究が激化するにつれ、汎用性の高い抗体への需要が高まっています。診断では、ポリクローナル抗体は正確な検出において極めて重要な役割を果たし、治療用途では様々な病状に対応します。これらの領域における継続的な進歩や研究活動の増加により、ポリクローナル抗体業界は拡大し、医療やバイオテクノロジー分野における診断や治療用途の多様なニーズに応えていくでしょう。

ライフサイエンスやバイオテクノロジーの分野では、研究用のポリクローナル抗体の開発に積極的に取り組んでいる組織があります。このことは、多様な研究ニーズを満たし、科学的応用を進展させることで、ポリクローナル抗体市場の強化に大きく貢献しています。例えば、2022年、バイオメディカルとライフサイエンスに不可欠な製品とサービスを専門とする販売業者であるAmerigo Scientificは、ヒト血液凝固第XIII因子を標的とする新しいポリクローナル抗体を発表しました。この抗体は研究専用に設計されており、ライフサイエンス研究者が血液凝固第XIII因子を検出するのに役立ちます。この抗体は、ヒトへの投与、治療、診断への応用を意図したものではありません。

ポリクローナル抗体業界は、用途、エンドユーザー、地域によって区分されます。

受託研究機関（CRO）分野は、抗体開発の専門知識を提供する受託研究サービスにおけるCROの極めて重要な役割に牽引され、2032年までに大きなシェアを確保すると思われます。バイオ医薬品開発において、オーダーメイドのソリューションに対する需要が高まる中、CROは専門的なサービスを提供する重要なパートナーとして機能しています。高品質のポリクローナル抗体作製に熟達したCROは、この分野を重要な牽引役として位置づけ、製薬・バイオテクノロジー業界の特定のニーズに対応し、科学研究の発展に重要な役割を果たします。

研究用途分野は、2032年まで大きなシェアを占めると思われます。これは、特にライフサイエンスとバイオテクノロジーの分野で、多様な研究用途に抗体が不可欠な役割を果たしているためです。実験、診断、治療研究に広く使用されていることが、その重要性を裏付けています。科学的な理解を深めることがますます重視される中、研究用途分野はポリクローナル抗体市場を形成する礎石となり、様々な分野の研究コミュニティの進化するニーズに応えていくと思われます。

欧州のポリクローナル抗体市場は、2023年～2032年に顕著なCAGRを記録し、同地域の堅調なバイオ医薬品業界と研究開発への多額の投資に後押しされる見込みです。欧州市場は、成熟した医療インフラと豊かな科学的景観の恩恵を受けており、ポリクローナル抗体用途の進歩を促進しています。慢性疾患の蔓延と標的治療薬への需要の高まりがこの地域の優位性を高め、ポリクローナル抗体業界の展望を形成する重要な力として欧州を位置づけています。

目次

第1章 調査手法と調査範囲

第2章 エグゼクティブサマリー

第3章 ポリクローナル抗体市場の洞察

• 業界情勢
• 業界への影響要因
  • 促進要因
  • 業界の潜在的リスクと課題
• 成長可能性分析
• COVID-19影響分析
• 規制状況
• ポーターの分析
• PESTEL分析
• パイプライン分析

第4章 競合情勢

• イントロダクション
• 企業マトリックス分析
• 主要市場企業の競合分析
• 競合のポジショニング・マトリックス
• 戦略ダッシュボード

第5章 ポリクローナル抗体の市場推計・予測：製品別（2018年～2032年）

• 主要動向：製品別
• 一次抗体
• 二次抗体

第6章 ポリクローナル抗体の市場推計・予測：用途別（2018年～2032年）

• 主要動向：用途別
• 診断薬
• 治療薬
• 研究

第7章 ポリクローナル抗体の市場推計・予測：投与経路別（2018年～2032年）

• 主要動向：投与経路別
• 静脈内（IV）
• 皮下（SC）
• その他

第8章 ポリクローナル抗体の市場推計・予測：供給源別（2018年～2032年）

• 主要動向：供給源別
• ウサギ
• ヤギ
• マウス
• ヒト
• その他

第9章 ポリクローナル抗体の市場推計・予測：エンドユーザー別（2018年～2032年）

• 主要動向：エンドユーザー別
• 製薬・バイオテクノロジー企業
• 学術・研究機関
• 医薬品開発業務受託機関（CRO）
• 診断研究所
• その他

第10章 ポリクローナル抗体の市場推計・予測：地域別（2018年～2032年）

• 主要動向：地域別
• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • 英国
  • フランス
  • スペイン
  • イタリア
  • その他欧州
• アジア太平洋
  • 中国
  • 日本
  • インド
  • オーストラリア
  • その他アジア太平洋
• ラテンアメリカ
  • ブラジル
  • メキシコ
  • その他ラテンアメリカ
• 中東・アフリカ
  • 南アフリカ
  • サウジアラビア
  • その他中東・アフリカ

第11章 企業プロファイル

• Thermo Fisher Scientific Inc.
• F. Hoffmann-La Roche Ltd.
• Merck Group（Merck KGaA）
• Abcam plc
• Bio-Rad Laboratories, Inc.
• GenScript Biotech Corporation
• Cell Signaling Technology, Inc.
• Rockland Immunochemicals Inc.
• BioLegend, Inc.
• Santa Cruz Biotechnology, Inc.
• Antibodies Inc.
• Emergent

Data Tables

• TABLE 1 Market revenue, by product (2022)
• TABLE 2 Market revenue, by application (2022)
• TABLE 3 Market revenue, by route of administration (2022)
• TABLE 4 Market revenue, by source (2022)
• TABLE 5 Market revenue, by end-user (2022)
• TABLE 6 Market share, by region (2022)
• TABLE 7 Global polyclonal antibodies market size, by region, 2018 - 2022 (USD Million)
• TABLE 8 Global polyclonal antibodies market size, by region, 2023 - 2032 (USD Million)
• TABLE 9 Global polyclonal antibodies market size, by product, 2018 - 2022 (USD Million)
• TABLE 10 Global polyclonal antibodies market size, by product, 2023 - 2032 (USD Million)
• TABLE 11 Global polyclonal antibodies market size, by application, 2018 - 2022 (USD Million)
• TABLE 12 Global polyclonal antibodies market size, by application, 2023 - 2032 (USD Million)
• TABLE 13 Global polyclonal antibodies market size, by route of administration, 2018 - 2022 (USD Million)
• TABLE 14 Global polyclonal antibodies market size, by route of administration, 2023 - 2032 (USD Million)
• TABLE 15 Global polyclonal antibodies market size, by source, 2018 - 2022 (USD Million)
• TABLE 16 Global polyclonal antibodies market size, by source, 2023 - 2032 (USD Million)
• TABLE 17 Global polyclonal antibodies market size, by end-user, 2018 - 2022 (USD Million)
• TABLE 18 Global polyclonal antibodies market size, by end-user, 2023 - 2032 (USD Million)
• TABLE 19 Industry impact forces
• TABLE 20 Primary antibodies market, 2018 - 2022 (USD Million)
• TABLE 21 Primary antibodies market, 2023 - 2032 (USD Million)
• TABLE 22 Secondary antibodies market, 2018 - 2022 (USD Million)
• TABLE 23 Secondary antibodies market, 2023 - 2032 (USD Million)
• TABLE 24 Diagnostics market, 2018 - 2022 (USD Million)
• TABLE 25 Diagnostics market, 2023 - 2032 (USD Million)
• TABLE 26 Therapeutics market, 2018 - 2022 (USD Million)
• TABLE 27 Therapeutics market, 2023 - 2032 (USD Million)
• TABLE 28 Research market, 2018 - 2022 (USD Million)
• TABLE 29 Research market, 2023 - 2032 (USD Million)
• TABLE 30 Intravenous (IV)market, 2018 - 2022 (USD Million)
• TABLE 31 Intravenous (IV)market, 2023 - 2032 (USD Million
• TABLE 32 Subcutaneous (SC)market, 2018 - 2022 (USD Million)
• TABLE 33 Subcutaneous (SC)market, 2023 - 2032 (USD Million
• TABLE 34 Other routes of administration market by end-user, 2018 - 2022 (USD Million)
• TABLE 35 Other routes of administration market, 2023 - 2032 (USD Million)
• TABLE 36 Rabbit market, 2018 - 2022 (USD Million)
• TABLE 37 Rabbit market, 2023 - 2032 (USD Million)
• TABLE 38 Goat market, 2018 - 2022 (USD Million)
• TABLE 39 Goat market, 2023 - 2032 (USD Million)
• TABLE 40 Mouse market, 2018 - 2022 (USD Million)
• TABLE 41 Mouse market, 2023 - 2032 (USD Million)
• TABLE 42 Human market, 2018 - 2022 (USD Million)
• TABLE 43 Human market, 2023 - 2032 (USD Million)
• TABLE 44 Other sources market, 2018 - 2022 (USD Million)
• TABLE 45 Other sources market, 2023 - 2032 (USD Million)
• TABLE 46 Pharmaceutical and biotechnology companies market, 2018 - 2022 (USD Million)
• TABLE 47 Pharmaceutical and biotechnology companies market, 2023 - 2032 (USD Million)
• TABLE 48 Academic and research institutes market, 2018 - 2022 (USD Million)
• TABLE 49 Academic and research institutes market, 2023 - 2032 (USD Million)
• TABLE 50 Contract research organizations (CROs) market, 2018 - 2022 (USD Million)
• TABLE 51 Contract research organizations (CROs) market, 2023 - 2032 (USD Million)
• TABLE 52 Diagnostic laboratories market, 2018 - 2022 (USD Million)
• TABLE 53 Diagnostic laboratories market, 2023 - 2032 (USD Million)
• TABLE 54 Other end-users market, 2018 - 2022 (USD Million)
• TABLE 55 Other end-users market, 2023 - 2032 (USD Million)
• TABLE 56 North America polyclonal antibodies market size, by country, 2018 - 2022 (USD Million)
• TABLE 57 North America polyclonal antibodies market size, by country, 2023 - 2032 (USD Million)
• TABLE 58 North America polyclonal antibodies market size, by product, 2018 - 2022 (USD Million)
• TABLE 59 North America polyclonal antibodies market size, by product, 2023 - 2032 (USD Million)
• TABLE 60 North America polyclonal antibodies market size, by application, 2018 - 2022 (USD Million)
• TABLE 61 North America polyclonal antibodies market size, by application, 2023 - 2032 (USD Million)
• TABLE 62 North America polyclonal antibodies market size, by route of administration, 2018 - 2022 (USD Million)
• TABLE 63 North America polyclonal antibodies market size, by route of administration, 2023 - 2032 (USD Million)
• TABLE 64 North America polyclonal antibodies market size, by source, 2018 - 2022 (USD Million)
• TABLE 65 North America polyclonal antibodies market size, by source, 2023 - 2032 (USD Million)
• TABLE 66 North America polyclonal antibodies market size, by end-user, 2018 - 2022 (USD Million)
• TABLE 67 North America polyclonal antibodies market size, by end-user, 2023 - 2032 (USD Million)
• TABLE 68 U.S. polyclonal antibodies market size, by product, 2018 - 2022 (USD Million)
• TABLE 69 U.S. polyclonal antibodies market size, by product, 2023 - 2032 (USD Million)
• TABLE 70 U.S. polyclonal antibodies market size, by application, 2018 - 2022 (USD Million)
• TABLE 71 U.S. polyclonal antibodies market size, by application, 2023 - 2032 (USD Million)
• TABLE 72 U.S. polyclonal antibodies market size, by route of administration, 2018 - 2022 (USD Million)
• TABLE 73 U.S. polyclonal antibodies market size, by route of administration, 2023 - 2032 (USD Million)
• TABLE 74 U.S. polyclonal antibodies market size, by source, 2018 - 2022 (USD Million)
• TABLE 75 U.S. polyclonal antibodies market size, by source, 2023 - 2032 (USD Million)
• TABLE 76 U.S. polyclonal antibodies market size, by end-user, 2018 - 2022 (USD Million)
• TABLE 77 U.S. polyclonal antibodies market size, by end-user, 2023 - 2032 (USD Million)
• TABLE 78 Canada polyclonal antibodies market size, by product, 2018 - 2022 (USD Million)
• TABLE 79 Canada polyclonal antibodies market size, by product, 2023 - 2032 (USD Million)
• TABLE 80 Canada polyclonal antibodies market size, by application, 2018 - 2022 (USD Million)
• TABLE 81 Canada polyclonal antibodies market size, by application, 2023 - 2032 (USD Million)
• TABLE 82 Canada polyclonal antibodies market size, by route of administration, 2018 - 2022 (USD Million)
• TABLE 83 Canada polyclonal antibodies market size, by route of administration, 2023 - 2032 (USD Million)
• TABLE 84 Canada polyclonal antibodies market size, by source, 2018 - 2022 (USD Million)
• TABLE 85 Canada polyclonal antibodies market size, by source, 2023 - 2032 (USD Million)
• TABLE 86 Canada polyclonal antibodies market size, by end-user, 2018 - 2022 (USD Million)
• TABLE 87 Canada polyclonal antibodies market size, by end-user, 2023 - 2032 (USD Million)
• TABLE 88 Europe polyclonal antibodies market size, by country, 2018 - 2022 (USD Million)
• TABLE 89 Europe polyclonal antibodies market size, by country, 2023 - 2032 (USD Million)
• TABLE 90 Europe polyclonal antibodies market size, by product, 2018 - 2022 (USD Million)
• TABLE 91 Europe polyclonal antibodies market size, by product, 2023 - 2032 (USD Million)
• TABLE 92 Europe polyclonal antibodies market size, by application, 2018 - 2022 (USD Million)
• TABLE 93 Europe polyclonal antibodies market size, by application, 2023 - 2032 (USD Million)
• TABLE 94 Europe polyclonal antibodies market size, by route of administration, 2018 - 2022 (USD Million)
• TABLE 95 Europe polyclonal antibodies market size, by route of administration, 2023 - 2032 (USD Million)
• TABLE 96 Europe polyclonal antibodies market size, by source, 2018 - 2022 (USD Million)
• TABLE 97 Europe polyclonal antibodies market size, by source, 2023 - 2032 (USD Million)
• TABLE 98 Europe polyclonal antibodies market size, by end-user, 2018 - 2022 (USD Million)
• TABLE 99 Europe polyclonal antibodies market size, by end-user, 2023 - 2032 (USD Million)
• TABLE 100 Germany polyclonal antibodies market size, by product, 2018 - 2022 (USD Million)
• TABLE 101 Germany polyclonal antibodies market size, by product, 2023 - 2032 (USD Million)
• TABLE 102 Germany polyclonal antibodies market size, by application, 2018 - 2022 (USD Million)
• TABLE 103 Germany polyclonal antibodies market size, by application, 2023 - 2032 (USD Million)
• TABLE 104 Germany polyclonal antibodies market size, by route of administration, 2018 - 2022 (USD Million)
• TABLE 105 Germany polyclonal antibodies market size, by route of administration, 2023 - 2032 (USD Million)
• TABLE 106 Germany polyclonal antibodies market size, by source, 2018 - 2022 (USD Million)
• TABLE 107 Germany polyclonal antibodies market size, by source, 2023 - 2032 (USD Million)
• TABLE 108 Germany polyclonal antibodies market size, by end-user, 2018 - 2022 (USD Million)
• TABLE 109 Germany polyclonal antibodies market size, by end-user, 2023 - 2032 (USD Million)
• TABLE 110 UK polyclonal antibodies market size, by product, 2018 - 2022 (USD Million)
• TABLE 111 UK polyclonal antibodies market size, by product, 2023 - 2032 (USD Million)
• TABLE 112 UK polyclonal antibodies market size, by application, 2018 - 2022 (USD Million)
• TABLE 113 UK polyclonal antibodies market size, by application, 2023 - 2032 (USD Million)
• TABLE 114 UK polyclonal antibodies market size, by route of administration, 2018 - 2022 (USD Million)
• TABLE 115 UK polyclonal antibodies market size, by route of administration, 2023 - 2032 (USD Million)
• TABLE 116 UK polyclonal antibodies market size, by source, 2018 - 2022 (USD Million)
• TABLE 117 UK polyclonal antibodies market size, by source, 2023 - 2032 (USD Million)
• TABLE 118 UK polyclonal antibodies market size, by end-user, 2018 - 2022 (USD Million)
• TABLE 119 UK polyclonal antibodies market size, by end-user, 2023 - 2032 (USD Million)
• TABLE 120 France polyclonal antibodies market size, by product, 2018 - 2022 (USD Million)
• TABLE 121 France polyclonal antibodies market size, by product, 2023 - 2032 (USD Million)
• TABLE 122 France polyclonal antibodies market size, by application, 2018 - 2022 (USD Million)
• TABLE 123 France polyclonal antibodies market size, by application, 2023 - 2032 (USD Million)
• TABLE 124 France polyclonal antibodies market size, by route of administration, 2018 - 2022 (USD Million)
• TABLE 125 France polyclonal antibodies market size, by route of administration, 2023 - 2032 (USD Million)
• TABLE 126 France polyclonal antibodies market size, by source, 2018 - 2022 (USD Million)
• TABLE 127 France polyclonal antibodies market size, by source, 2023 - 2032 (USD Million)
• TABLE 128 France polyclonal antibodies market size, by end-user, 2018 - 2022 (USD Million)
• TABLE 129 France polyclonal antibodies market size, by end-user, 2023 - 2032 (USD Million)
• TABLE 130 Spain polyclonal antibodies market size, by product, 2018 - 2022 (USD Million)
• TABLE 131 Spain polyclonal antibodies market size, by product, 2023 - 2032 (USD Million)
• TABLE 132 Spain polyclonal antibodies market size, by application, 2018 - 2022 (USD Million)
• TABLE 133 Spain polyclonal antibodies market size, by application, 2023 - 2032 (USD Million
• TABLE 134 Spain polyclonal antibodies market size, by route of administration, 2018 - 2022 (USD Million)
• TABLE 135 Spain polyclonal antibodies market size, by route of administration, 2023 - 2032 (USD Million)
• TABLE 136 Spain polyclonal antibodies market size, by source, 2018 - 2022 (USD Million)
• TABLE 137 Spain polyclonal antibodies market size, by source, 2023 - 2032 (USD Million)
• TABLE 138 Spain polyclonal antibodies market size, by end-user, 2018 - 2022 (USD Million)
• TABLE 139 Spain polyclonal antibodies market size, by end-user, 2023 - 2032 (USD Million)
• TABLE 140 Italy polyclonal antibodies market size, by product, 2018 - 2022 (USD Million)
• TABLE 141 Italy polyclonal antibodies market size, by product, 2023 - 2032 (USD Million)
• TABLE 142 Italy polyclonal antibodies market size, by application, 2018 - 2022 (USD Million)
• TABLE 143 Italy polyclonal antibodies market size, by application, 2023 - 2032 (USD Million)
• TABLE 144 Italy polyclonal antibodies market size, by route of administration, 2018 - 2022 (USD Million)
• TABLE 145 Italy polyclonal antibodies market size, by route of administration, 2023 - 2032 (USD Million)
• TABLE 146 Italy polyclonal antibodies market size, by source, 2018 - 2022 (USD Million)
• TABLE 147 Italy polyclonal antibodies market size, by source, 2023 - 2032 (USD Million)
• TABLE 148 Italy polyclonal antibodies market size, by end-user, 2018 - 2022 (USD Million)
• TABLE 149 Italy polyclonal antibodies market size, by end-user, 2023 - 2032 (USD Million)
• TABLE 150 Rest of Europe polyclonal antibodies market size, by product, 2018 - 2022 (USD Million)
• TABLE 151 Rest of Europe polyclonal antibodies market size, by product, 2023 - 2032 (USD Million)
• TABLE 152 Rest of Europe polyclonal antibodies market size, by application, 2018 - 2022 (USD Million)
• TABLE 153 Rest of Europe polyclonal antibodies market size, by application, 2023 - 2032 (USD Million)
• TABLE 154 Rest of Europe polyclonal antibodies market size, by route of administration, 2018 - 2022 (USD Million)
• TABLE 155 Rest of Europe polyclonal antibodies market size, by route of administration, 2023 - 2032 (USD Million)
• TABLE 156 Rest of Europe polyclonal antibodies market size, by source, 2018 - 2022 (USD Million)
• TABLE 157 Rest of Europe polyclonal antibodies market size, by source, 2023 - 2032 (USD Million)
• TABLE 158 Rest of Europe polyclonal antibodies market size, by end-user, 2018 - 2022 (USD Million)
• TABLE 159 Rest of Europe polyclonal antibodies market size, by end-user, 2023 - 2032 (USD Million)
• TABLE 160 Asia Pacific polyclonal antibodies market size, by country, 2018 - 2022 (USD Million)
• TABLE 161 Asia Pacific polyclonal antibodies market size, by country, 2023 - 2032 (USD Million)
• TABLE 162 Asia Pacific polyclonal antibodies market size, by product, 2018 - 2022 (USD Million)
• TABLE 163 Asia Pacific polyclonal antibodies market size, by product, 2023 - 2032 (USD Million)
• TABLE 164 Asia Pacific polyclonal antibodies market size, by application, 2018 - 2022 (USD Million)
• TABLE 165 Asia Pacific polyclonal antibodies market size, by application, 2023 - 2032 (USD Million)
• TABLE 166 Asia Pacific polyclonal antibodies market size, by route of administration, 2018 - 2022 (USD Million)
• TABLE 167 Asia Pacific polyclonal antibodies market size, by route of administration, 2023 - 2032 (USD Million)
• TABLE 168 Asia Pacific polyclonal antibodies market size, by source, 2018 - 2022 (USD Million)
• TABLE 169 Asia Pacific polyclonal antibodies market size, by source, 2023 - 2032 (USD Million)
• TABLE 170 Asia Pacific polyclonal antibodies market size, by end-user, 2018 - 2022 (USD Million)
• TABLE 171 Asia Pacific polyclonal antibodies market size, by end-user, 2023 - 2032 (USD Million)
• TABLE 172 China polyclonal antibodies market size, by product, 2018 - 2022 (USD Million)
• TABLE 173 China polyclonal antibodies market size, by product, 2023 - 2032 (USD Million)
• TABLE 174 China polyclonal antibodies market size, by application, 2018 - 2022 (USD Million)
• TABLE 175 China polyclonal antibodies market size, by application, 2023 - 2032 (USD Million)
• TABLE 176 China polyclonal antibodies market size, by route of administration, 2018 - 2022 (USD Million)
• TABLE 177 China polyclonal antibodies market size, by route of administration, 2023 - 2032 (USD Million)
• TABLE 178 China polyclonal antibodies market size, by source, 2018 - 2022 (USD Million)
• TABLE 179 China polyclonal antibodies market size, by source, 2023 - 2032 (USD Million)
• TABLE 180 China polyclonal antibodies market size, by end-user, 2018 - 2022 (USD Million)
• TABLE 181 China polyclonal antibodies market size, by end-user, 2023 - 2032 (USD Million)
• TABLE 182 Japan polyclonal antibodies market size, by product, 2018 - 2022 (USD Million)
• TABLE 183 Japan polyclonal antibodies market size, by product, 2023 - 2032 (USD Million)
• TABLE 184 Japan polyclonal antibodies market size, by application, 2018 - 2022 (USD Million)
• TABLE 185 Japan polyclonal antibodies market size, by application, 2023 - 2032 (USD Million)
• TABLE 186 Japan polyclonal antibodies market size, by route of administration, 2018 - 2022 (USD Million)
• TABLE 187 Japan polyclonal antibodies market size, by route of administration, 2023 - 2032 (USD Million)
• TABLE 188 Japan polyclonal antibodies market size, by source, 2018 - 2022 (USD Million)
• TABLE 189 Japan polyclonal antibodies market size, by source, 2023 - 2032 (USD Million)
• TABLE 190 Japan polyclonal antibodies market size, by end-user, 2018 - 2022 (USD Million)
• TABLE 191 Japan polyclonal antibodies market size, by end-user, 2023 - 2032 (USD Million)
• TABLE 192 India polyclonal antibodies market size, by product, 2018 - 2022 (USD Million)
• TABLE 193 India polyclonal antibodies market size, by product, 2023 - 2032 (USD Million)
• TABLE 194 India polyclonal antibodies market size, by application, 2018 - 2022 (USD Million)
• TABLE 195 India polyclonal antibodies market size, by application, 2023 - 2032 (USD Million)
• TABLE 196 India polyclonal antibodies market size, by route of administration, 2018 - 2022 (USD Million)
• TABLE 197 India polyclonal antibodies market size, by route of administration, 2023 - 2032 (USD Million)
• TABLE 198 India polyclonal antibodies market size, by source, 2018 - 2022 (USD Million)
• TABLE 199 India polyclonal antibodies market size, by source, 2023 - 2032 (USD Million)
• TABLE 200 India polyclonal antibodies market size, by end-user, 2018 - 2022 (USD Million)
• TABLE 201 India polyclonal antibodies market size, by end-user, 2023 - 2032 (USD Million)
• TABLE 202 Australia polyclonal antibodies market size, by product, 2018 - 2022 (USD Million)
• TABLE 203 Australia polyclonal antibodies market size, by product, 2023 - 2032 (USD Million)
• TABLE 204 Australia polyclonal antibodies market size, by application, 2018 - 2022 (USD Million)
• TABLE 205 Australia polyclonal antibodies market size, by application, 2023 - 2032 (USD Million)
• TABLE 206 Australia polyclonal antibodies market size, by route of administration, 2018 - 2022 (USD Million)
• TABLE 207 Australia polyclonal antibodies market size, by route of administration, 2023 - 2032 (USD Million)
• TABLE 208 Australia polyclonal antibodies market size, by source, 2018 - 2022 (USD Million)
• TABLE 209 Australia polyclonal antibodies market size, by source, 2023 - 2032 (USD Million)
• TABLE 210 Australia polyclonal antibodies market size, by end-user, 2018 - 2022 (USD Million)
• TABLE 211 Australia polyclonal antibodies market size, by end-user, 2023 - 2032 (USD Million)
• TABLE 212 Rest of Asia Pacific polyclonal antibodies market size, by product, 2018 - 2022 (USD Million)
• TABLE 213 Rest of Asia Pacific polyclonal antibodies market size, by product, 2023 - 2032 (USD Million)
• TABLE 214 Rest of Asia Pacific polyclonal antibodies market size, by application, 2018 - 2022 (USD Million)
• TABLE 215 Rest of Asia Pacific polyclonal antibodies market size, by application, 2023 - 2032 (USD Million)
• TABLE 216 Rest of Asia Pacific polyclonal antibodies market size, by route of administration, 2018 - 2022 (USD Million)
• TABLE 217 Rest of Asia Pacific polyclonal antibodies market size, by route of administration, 2023 - 2032 (USD Million)
• TABLE 218 Rest of Asia Pacific polyclonal antibodies market size, by source, 2018 - 2022 (USD Million)
• TABLE 219 Rest of Asia Pacific polyclonal antibodies market size, by source, 2023 - 2032 (USD Million)
• TABLE 220 Rest of Asia Pacific polyclonal antibodies market size, by end-user, 2018 - 2022 (USD Million)
• TABLE 221 Rest of Asia Pacific polyclonal antibodies market size, by end-user, 2023 - 2032 (USD Million)
• TABLE 222 Latin America polyclonal antibodies market size, by country, 2018 - 2022 (USD Million)
• TABLE 223 Latin America polyclonal antibodies market size, by country, 2023 - 2032 (USD Million)
• TABLE 224 Latin America polyclonal antibodies market size, by product, 2018 - 2022 (USD Million)
• TABLE 225 Latin America polyclonal antibodies market size, by product, 2023 - 2032 (USD Million)
• TABLE 226 Latin America polyclonal antibodies market size, by application, 2018 - 2022 (USD Million)
• TABLE 227 Latin America polyclonal antibodies market size, by application, 2023 - 2032 (USD Million)
• TABLE 228 Latin America polyclonal antibodies market size, by route of administration, 2018 - 2022 (USD Million)
• TABLE 229 Latin America polyclonal antibodies market size, by route of administration, 2023 - 2032 (USD Million)
• TABLE 230 Latin America polyclonal antibodies market size, by source, 2018 - 2022 (USD Million)
• TABLE 231 Latin America polyclonal antibodies market size, by source, 2023 - 2032 (USD Million)
• TABLE 232 Latin America polyclonal antibodies market size, by end-user, 2018 - 2022 (USD Million)
• TABLE 233 Latin America polyclonal antibodies market size, by end-user, 2023 - 2032 (USD Million)
• TABLE 234 Brazil polyclonal antibodies market size, by product, 2018 - 2022 (USD Million)
• TABLE 235 Brazil polyclonal antibodies market size, by product, 2023 - 2032 (USD Million)
• TABLE 236 Brazil polyclonal antibodies market size, by application, 2018 - 2022 (USD Million)
• TABLE 237 Brazil polyclonal antibodies market size, by application, 2023 - 2032 (USD Million)
• TABLE 238 Brazil polyclonal antibodies market size, by route of administration, 2018 - 2022 (USD Million)
• TABLE 239 Brazil polyclonal antibodies market size, by route of administration, 2023 - 2032 (USD Million)
• TABLE 240 Brazil polyclonal antibodies market size, by source, 2018 - 2022 (USD Million)
• TABLE 241 Brazil polyclonal antibodies market size, by source, 2023 - 2032 (USD Million)
• TABLE 242 Brazil polyclonal antibodies market size, by end-user, 2018 - 2022 (USD Million)
• TABLE 243 Brazil polyclonal antibodies market size, by end-user, 2023 - 2032 (USD Million)
• TABLE 244 Mexico polyclonal antibodies market size, by product, 2018 - 2022 (USD Million)
• TABLE 245 Mexico polyclonal antibodies market size, by product, 2023 - 2032 (USD Million)
• TABLE 246 Mexico polyclonal antibodies market size, by application, 2018 - 2022 (USD Million)
• TABLE 247 Mexico polyclonal antibodies market size, by application, 2023 - 2032 (USD Million)
• TABLE 248 Mexico polyclonal antibodies market size, by route of administration, 2018 - 2022 (USD Million)
• TABLE 249 Mexico polyclonal antibodies market size, by route of administration, 2023 - 2032 (USD Million)
• TABLE 250 Mexico polyclonal antibodies market size, by source, 2018 - 2022 (USD Million)
• TABLE 251 Mexico polyclonal antibodies market size, by source, 2023 - 2032 (USD Million)
• TABLE 252 Mexico polyclonal antibodies market size, by end-user, 2018 - 2022 (USD Million)
• TABLE 253 Mexico polyclonal antibodies market size, by end-user, 2023 - 2032 (USD Million)
• TABLE 254 Rest of Latin America polyclonal antibodies market size, by product, 2018 - 2022 (USD Million)
• TABLE 255 Rest of Latin America polyclonal antibodies market size, by product, 2023 - 2032 (USD Million)
• TABLE 256 Rest of Latin America polyclonal antibodies market size, by application, 2018 - 2022 (USD Million)
• TABLE 257 Rest of Latin America polyclonal antibodies market size, by application, 2023 - 2032 (USD Million)
• TABLE 258 Rest of Latin America polyclonal antibodies market size, by route of administration, 2018 - 2022 (USD Million)
• TABLE 259 Rest of Latin America polyclonal antibodies market size, by route of administration, 2023 - 2032 (USD Million)
• TABLE 260 Rest of Latin America polyclonal antibodies market size, by source, 2018 - 2022 (USD Million)
• TABLE 261 Rest of Latin America polyclonal antibodies market size, by source, 2023 - 2032 (USD Million)
• TABLE 262 Rest of Latin America polyclonal antibodies market size, by end-user, 2018 - 2022 (USD Million)
• TABLE 263 Rest of Latin America polyclonal antibodies market size, by end-user, 2023 - 2032 (USD Million)
• TABLE 264 Middle East & Africa polyclonal antibodies market size, by country, 2018 - 2022 (USD Million)
• TABLE 265 Middle East & Africa polyclonal antibodies market size, by country, 2023 - 2032 (USD Million)
• TABLE 266 Middle East & Africa polyclonal antibodies market size, by product, 2018 - 2022 (USD Million)
• TABLE 267 Middle East & Africa polyclonal antibodies market size, by product, 2023 - 2032 (USD Million)
• TABLE 268 Middle East & Africa polyclonal antibodies market size, by application, 2018 - 2022 (USD Million)
• TABLE 269 Middle East & Africa polyclonal antibodies market size, by application, 2023 - 2032 (USD Million)
• TABLE 270 Middle East & Africa polyclonal antibodies market size, by route of administration, 2018 - 2022 (USD Million)
• TABLE 271 Middle East & Africa polyclonal antibodies market size, by route of administration, 2023 - 2032 (USD Million)
• TABLE 272 Middle East & Africa polyclonal antibodies market size, by source, 2018 - 2022 (USD Million)
• TABLE 273 Middle East & Africa polyclonal antibodies market size, by source, 2023 - 2032 (USD Million)
• TABLE 274 Middle East & Africa polyclonal antibodies market size, by end-user, 2018 - 2022 (USD Million)
• TABLE 275 Middle East & Africa polyclonal antibodies market size, by end-user, 2023 - 2032 (USD Million)
• TABLE 276 South Africa polyclonal antibodies market size, by product, 2018 - 2022 (USD Million)
• TABLE 277 South Africa polyclonal antibodies market size, by product, 2023 - 2032 (USD Million)
• TABLE 278 South Africa polyclonal antibodies market size, by application, 2018 - 2022 (USD Million)
• TABLE 279 South Africa polyclonal antibodies market size, by application, 2023 - 2032 (USD Million)
• TABLE 280 South Africa polyclonal antibodies market size, by route of administration, 2018 - 2022 (USD Million)
• TABLE 281 South Africa polyclonal antibodies market size, by route of administration, 2023 - 2032 (USD Million)
• TABLE 282 South Africa polyclonal antibodies market size, by source, 2018 - 2022 (USD Million)
• TABLE 283 South Africa polyclonal antibodies market size, by source, 2023 - 2032 (USD Million)
• TABLE 284 South Africa polyclonal antibodies market size, by end-user, 2018 - 2022 (USD Million)
• TABLE 285 South Africa polyclonal antibodies market size, by end-user, 2023 - 2032 (USD Million)
• TABLE 286 Saudi Arabia polyclonal antibodies market size, by product, 2018 - 2022 (USD Million)
• TABLE 287 Saudi Arabia polyclonal antibodies market size, by product, 2023 - 2032 (USD Million)
• TABLE 288 Saudi Arabia polyclonal antibodies market size, by application, 2018 - 2022 (USD Million)
• TABLE 289 Saudi Arabia polyclonal antibodies market size, by application, 2023 - 2032 (USD Million
• TABLE 290 Saudi Arabia polyclonal antibodies market size, by route of administration, 2018 - 2022 (USD Million)
• TABLE 291 Saudi Arabia polyclonal antibodies market size, by route of administration, 2023 - 2032 (USD Million)
• TABLE 292 Saudi Arabia polyclonal antibodies market size, by source, 2018 - 2022 (USD Million)
• TABLE 293 Saudi Arabia polyclonal antibodies market size, by source, 2023 - 2032 (USD Million)
• TABLE 294 Saudi Arabia polyclonal antibodies market size, by end-user, 2018 - 2022 (USD Million)
• TABLE 295 Saudi Arabia polyclonal antibodies market size, by end-user, 2023 - 2032 (USD Million)
• TABLE 296 Rest of Middle East & Africa polyclonal antibodies market size, by product, 2018 - 2022 (USD Million)
• TABLE 297 Rest of Middle East & Africa polyclonal antibodies market size, by product, 2023 - 2032 (USD Million)
• TABLE 298 Rest of Middle East & Africa polyclonal antibodies market size, by application, 2023 - 2032 (USD Million)
• TABLE 299 Rest of Middle East & Africa polyclonal antibodies market size, by application, 2018 - 2022 (USD Million)
• TABLE 300 Rest of Middle East & Africa polyclonal antibodies market size, by route of administration, 2018 - 2022 (USD Million)
• TABLE 301 Rest of Middle East & Africa polyclonal antibodies market size, by route of administration, 2023 - 2032 (USD Million)
• TABLE 302 Rest of Middle East & Africa polyclonal antibodies market size, by source, 2018 - 2022 (USD Million)
• TABLE 303 Rest of Middle East & Africa polyclonal antibodies market size, by source, 2023 - 2032 (USD Million)
• TABLE 304 Rest of Middle East & Africa polyclonal antibodies market size, by end-user, 2018 - 2022 (USD Million)
• TABLE 305 Rest of Middle East & Africa polyclonal antibodies market size, by end-user, 2023 - 2032 (USD Million)

Charts & Figures

• FIG 1 GMI report coverage: critical research elements
• FIG 2 Top-down approach
• FIG 3 Market estimation and forecast methodology
• FIG 4 Market forecasting methodology
• FIG 5 Breakdown of primary participants
• FIG 6 Polyclonal antibodies market industry 360 degree synopsis, 2018 - 2032
• FIG 7 Growth potential analysis, by product
• FIG 8 Growth potential analysis, by application
• FIG 9 Growth potential analysis, by route of administration
• FIG 10 Growth potential analysis, by source
• FIG 11 Growth potential analysis, by end-user
• FIG 12 Porter's analysis
• FIG 13 PESTEL analysis
• FIG 14 Company matrix analysis, 2022
• FIG 15 Competitive analysis of major market players, 2022
• FIG 16 Competitive positioning matrix, 2022
• FIG 17 Strategic dashboard, 2022

Global Polyclonal Antibodies Market size will grow at a 5.9% CAGR from 2023 to 2032 due to expanding application scope in diagnostics, therapeutics, and experimental research. As life sciences and biotechnology research intensifies, there is a heightened demand for versatile antibodies. In diagnostics, polyclonal antibodies play a pivotal role in accurate detection, while their therapeutic applications address various medical conditions. With ongoing advancements and increased research activities in these domains, the polyclonal antibodies industry will expand, meeting the diverse needs of diagnostic and therapeutic applications within the healthcare and biotechnology sectors.

Organizations are actively engaged in developing polyclonal antibodies for research in the life sciences and biotechnology sectors. This contributes significantly to bolstering the polyclonal antibodies market by meeting diverse research needs and advancing scientific applications. For instance, in 2022, Amerigo Scientific, a distributor specializing in essential products and services for the biomedical and life sciences, unveiled a new polyclonal antibody targeting human blood coagulation factor XIII. Designed exclusively for research purposes, this antibody aids life science researchers in detecting blood coagulation factor XIII. It is expressly not intended for human, therapeutic, or diagnostic applications.

The polyclonal antibodies industry is segmented based on application, end-user, and region.

The contract research organizations (CROs) segment will secure a significant share by 2032, driven by CROs' pivotal role in outsourced research services, offering expertise in antibody development. With a rising demand for tailored solutions in biopharmaceutical development, CROs serve as essential partners, providing specialized services. Their proficiency in generating high-quality polyclonal antibodies will position the segment as a key driver, addressing the specific needs of the pharmaceutical and biotechnology industries and playing a crucial role in advancing scientific research.

The research application segment will capture a substantial share through 2032, attributed to the integral role these antibodies play in diverse research applications, particularly in life sciences and biotechnology. Their widespread use in experiments, diagnostics, and therapeutic research underscores their significance. With an increasing emphasis on advancing scientific understanding, the research application segment will be a cornerstone in shaping the polyclonal antibodies market, meeting the evolving needs of the research community across various disciplines.

Europe polyclonal antibodies market will register a notable CAGR from 2023 to 2032, propelled by the region's robust biopharmaceutical industry and substantial investments in research and development. The European market benefits from a mature healthcare infrastructure and a rich scientific landscape, fostering advancements in polyclonal antibody applications. The prevalence of chronic diseases and increasing demand for targeted therapeutics contribute to the region's prominence, positioning Europe as a significant force in shaping the polyclonal antibodies industry outlook.

Table of Contents

Chapter 1 Methodology & Scope

• 1.1 Market definition
• 1.2 Base estimates & calculations
• 1.3 Forecast Calculation
• 1.4 COVID-19 impact analysis at global level
• 1.5 Data validation
• 1.6 Data sources
  • 1.6.1 Primary
  • 1.6.2 Secondary
    • 1.6.2.1 Paid sources
    • 1.6.2.2 Public sources

Chapter 2 Executive Summary

• 2.1 Polyclonal antibodies industry 360 degree synopsis, 2018 - 2032 (USD Million)
  • 2.1.1 Business trends
  • 2.1.2 Regional trends
  • 2.1.3 Product trends
  • 2.1.4 Application trends
  • 2.1.5 Route of administration trends
  • 2.1.6 Source trends
  • 2.1.7 End-user trends

Chapter 3 Polyclonal Antibodies Market Insights

• 3.1 Industry landscape, 2018 - 2032 (USD Million)
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Increasing prevalence of chronic and infectious diseases
    • 3.2.1.2 Growing demand for personalized medicines
    • 3.2.1.3 Increasing biopharmaceutical R&D activities
  • 3.2.2 Industry pitfalls & challenges
    • 3.2.2.1 Stringency of regulatory procedures
• 3.3 Growth potential analysis
  • 3.3.1 By product
  • 3.3.2 By application
  • 3.3.3 By route of administration
  • 3.3.4 By source
  • 3.3.5 By end-users
• 3.4 COVID-19 impact analysis
• 3.5 Regulatory landscape
• 3.6 Porter's analysis
• 3.7 PESTEL analysis
• 3.8 Pipeline Analysis

Chapter 4 Competitive Landscape, 2022

• 4.1 Introduction
• 4.2 Company matrix analysis, 2022
• 4.3 Competitive analysis of major market players, 2022
• 4.4 Competitive positioning matrix, 2022
• 4.5 Strategic dashboard, 2022

Chapter 5 Polyclonal Antibodies Market Estimates and Forecast, By Product, 2018-2032 (USD Million)

• 5.1 Key trends, by product
• 5.2 Primary antibodies
• 5.3 Secondary antibodies

Chapter 6 Polyclonal Antibodies Market Estimates and Forecast, By Application, 2018-2032 (USD Million)

• 6.1 Key trends, by application
• 6.2 Diagnostics
• 6.3 Therapeutics
• 6.4 Research

Chapter 7 Polyclonal Antibodies Market Estimates and Forecast, By Route of Administration, 2018-2032 (USD Million)

• 7.1 Key trends, by route of administration
• 7.2 Intravenous (IV)
• 7.3 Subcutaneous (SC)
• 7.4 Other routes of administration

Chapter 8 Polyclonal Antibodies Market Estimates and Forecast, By Source, 2018-2032 (USD Million)

• 8.1 Key trends, by source
• 8.2 Rabbit
• 8.3 Goat
• 8.4 Mouse
• 8.5 Human
• 8.6 Other sources

Chapter 9 Polyclonal Antibodies Market Estimates and Forecast, By End-users, 2018-2032 (USD Million)

• 9.1 Key trends, by end-user
• 9.2 Pharmaceutical and Biotechnology Companies
• 9.3 Academic and Research Institutes
• 9.4 Contract Research Organizations (CROs)
• 9.5 Diagnostic Laboratories
• 9.6 Other end-users

Chapter 10 Polyclonal Antibodies Market Estimates and Forecast, By Region, 2018 - 2032 (USD Million)

• 10.1 Key trends, by region
• 10.2 North America
  • 10.2.1 U.S.
  • 10.2.2 Canada
• 10.3 Europe
  • 10.3.1 Germany
  • 10.3.2 UK
  • 10.3.3 France
  • 10.3.4 Spain
  • 10.3.5 Italy
  • 10.3.6 Rest of Europe
• 10.4 Asia Pacific
  • 10.4.1 China
  • 10.4.2 Japan
  • 10.4.3 India
  • 10.4.4 Australia
  • 10.4.5 Rest of Asia Pacific
• 10.5 Latin America
  • 10.5.1 Brazil
  • 10.5.2 Mexico
  • 10.5.3 Rest of Latin America
• 10.6 Middle East & Africa
  • 10.6.1 South Africa
  • 10.6.2 Saudi Arabia
  • 10.6.3 Rest of Middle East & Africa

Chapter 11 Company Profiles

• 11.1 Thermo Fisher Scientific Inc.
• 11.2 F. Hoffmann-La Roche Ltd.
• 11.3 Merck Group (Merck KGaA)
• 11.4 Abcam plc
• 11.5 Bio-Rad Laboratories, Inc.
• 11.6 GenScript Biotech Corporation
• 11.7 Cell Signaling Technology, Inc.
• 11.8 Rockland Immunochemicals Inc.
• 11.9 BioLegend, Inc.
• 11.10 Santa Cruz Biotechnology, Inc.
• 11.11 Antibodies Inc.
• 11.12 Emergent